Brian Wetchler
Internal Medicine · Woodbury, NYNPI 1710253158
Payments from drug & device makers
Across 103 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$320
- Amgen$193
- Novo Nordisk$137
- Lilly USA, LLC$132
- Pfizer$116
- Merck$92
- plus $753 from 17 others
What the payments were for
- Food & beverage$1,743100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $320 |
| Amgen | 11 | $193 |
| Novo Nordisk | 8 | $137 |
| Lilly USA, LLC | 8 | $132 |
| Pfizer | 7 | $116 |
| Merck | 6 | $92 |
| Johnson & Johnson | 6 | $91 |
| AstraZeneca | 5 | $91 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| Amarin Pharma, Inc. | 4 | $71 |
| Boehringer Ingelheim | 4 | $70 |
| Novartis | 4 | $67 |
| Astellas Pharma US Inc | 3 | $53 |
| Sanofi Pasteur Inc. | 3 | $47 |
| Dexcom, Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| GSK | 1 | $15 |
| Heartflow, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$1,743 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 128 | $136,617 |
| OzempicSemaglutide | 97 | $112,683 |
| EliquisApixaban | 81 | $92,054 |
| JardianceEmpagliflozin | 91 | $85,023 |
| XareltoRivaroxaban | 16 | $17,701 |
| JanuviaSitagliptin Phosphate | 20 | $15,831 |
| TrulicityDulaglutide | 14 | $13,078 |
| Repatha SyringeEvolocumab | 13 | $12,040 |
| LivaloPitavastatin Calcium | 12 | $10,206 |
| SynthroidLevothyroxine Sodium | 98 | $9,941 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $7,515 |
| Rosuvastatin Calcium | 378 | $7,474 |
| FarxigaDapagliflozin Propanediol | 13 | $6,769 |
| VascepaIcosapent Ethyl | 17 | $6,185 |
| Dexlansoprazole DrDexlansoprazole | 20 | $5,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $132 | $149,695142 claims |
| Novo NordiskOzempic | $137 | $112,68397 claims |
| PfizerEliquis | $116 | $92,05481 claims |
| Boehringer IngelheimJardiance | $70 | $85,02391 claims |
| Johnson & JohnsonXarelto | $91 | $17,70116 claims |
| MerckJanuvia | $92 | $15,83120 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $31 | $10,20612 claims |
| AbbVieSynthroid | $320 | $9,94198 claims |
| GSKBreo Ellipta | $15 | $7,51519 claims |
| AstraZenecaFarxiga | $91 | $6,76913 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $3,389135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Woodbury
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.